ALVOW — Alvotech

—
Nasdaq · Health Care · Biotechnology · CIK 1898416 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 111,398,000 59,579,000 12,810,000 -74,868,000 1,616,043,000 61,468,000 1,883,310,000
Jun 2026 105,772,000 53,575,000 -11,705,000 -66,821,000 1,587,468,000 142,750,000 1,778,947,000
Mar 2026 105,865,000 59,778,000 9,674,000 1,030,000 1,421,168,000 63,832,000 1,703,480,000
Dec 2025 166,573,000 105,293,000 48,255,000 -108,547,000 1,487,099,000 172,359,000 1,771,586,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-198,702,000
Investing CF
$-146,183,000
Financing CF
$335,933,000
CapEx
$-135,122,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-2,475,581,000
Inventory
$226,551,000
Receivables
$132,381,000
ST Investments
—
EBIT TTM
$110,426,000
Pretax Income TTM
$-32,159,000
Interest Exp TTM
$142,585,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$494,608,000
EBITDA
$75,733,000
Free Cash Flow
$-123,130,128
Enterprise Value
—
Total Cash
$142,750,000
Total Debt
$1,451,784,960
Shares Out
—
Trailing EPS
—
Book Value
$-0.54
ROE
—
ROA
2.2%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 586,321,000 78,207,000 27,919,000 1,487,099,000 1,771,586,000 -284,487,000 -50,197,000
Dec 2024 489,682,000 69,644,000 -231,864,000 1,221,400,000 1,634,171,000 -412,771,000 -236,843,000
Dec 2023 91,434,000 -354,860,000 -551,731,000 950,090,000 1,882,583,000 -932,493,000 -312,185,000
Dec 2022 83,029,000 -346,442,000 -513,580,000 828,443,000 1,392,859,000 -564,416,000 -312,389,000

Peers — same industry

TickerNameMarket CapLastDaily %
AMGN AMGEN INC $247.70B $457.93 —
GILD GILEAD SCIENCES, INC. $211.18B $170.26 —
MRNA Moderna, Inc. $82.56B $206.80 —
ARGX ARGENX SE $58.92B $947.52 —
BIIB BIOGEN INC. $37.07B $250.79 —

News headlines (Yahoo Finance, 1h cache)

Amneal Announces European Approval of Adcomfo® (Omalizumab), a Biosimilar to XOLAIR®
2026-11-17 21:05 · Yahoo
Alvotech Stock After Earnings Loss What Changed
2026-11-15 08:12 · Yahoo
Alvotech (ALVO) Q3 2026 Earnings Call Transcript
2026-11-12 16:59 · Yahoo
What Alvotech (ALVO) Said on Its Q3 Earnings Call
2026-11-12 16:15 · Yahoo
Alvotech (ALVO) Reports Q3 Loss, Lags Revenue Estimates
2026-11-11 21:55 · Yahoo
Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
2026-11-11 21:15 · Yahoo
Editas Medicine (EDIT) Reports Q3 Loss, Tops Revenue Estimates
2026-11-09 12:25 · Yahoo
Is Alvotech (NASDAQ:ALVO) Trading At A Discount To Its Sales?
2026-11-08 07:08 · Yahoo
Alvotech (ALVO) Dropped, What Is Driving Attention Now?
2026-11-08 01:15 · Yahoo
Vericel Corporation (VCEL) Beats Q3 Earnings and Revenue Estimates
2026-11-05 13:35 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.